
Increasing demand for Covid vaccine injury payments has seen the number of staff processing claims increase 20-fold, figures show.
The Vaccine Damage Payment Scheme (VDPS) has scaled up operations and boosted its administrative staff from four to 80 to handle the claims.
A project is also under way to digitalise the application process to make it simpler and quicker for claimants.
But MPs, campaigners and families have called for the process to be reformed, arguing that the payment cap of £120,000 is too low, too slow and bureaucratic, and the eligibility criteria is too strict.




If someone had asked you in winter 2019 your views on gain-of-function research, you would likely have given them a blank look. But since the Covid pandemic, and with the Wall Street Journal revealing in February that the US Department of Energy now thinks Covid-19 is likely to have come from the Wuhan Institute of Virology, gain-of-function research — often conducted to make viruses more infectious and more deadly — is a matter of enormous significance and should be at the forefront of a national conversation about the very real 








